NCT03448536View on ClinicalTrials.gov

A Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea

PHASE4CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

April 5, 2018

Primary Completion Date

September 5, 2018

Study Completion Date

September 5, 2018

Conditions
Dysmenorrhea
Interventions
DRUG

Naproxen Sodium, (Aleve, BAY117031)

220 mg \*2 tablets, orally, single dose

DRUG

Acetaminophen (Tylenol Extra Strength)

500 mg \*2 caplets, orally, single dose

Trial Locations (8)

33781

Radiant Research, Inc., Pinellas Park

44311

Radiant Research, Inc., Akron

45236

Radiant Research, Inc., Cincinnati

60602

Radiant Research, Inc., Chicago

75234

Radiant Research, Inc., Dallas

Synexus US, LP- Plano, Plano

85224

Radiant Research, Inc., Chandler

85251

Radiant Research, Inc., Scottsdale

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT03448536 - A Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea | Biotech Hunter | Biotech Hunter